600511 國藥股份
按盤價 
29.280 -0.410 (-1.381%) | 2025/12 - 人民幣(K¥) | 變動 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 52,468,281 | 3.70% | 49,696,046 | 45,498,584 | 46,468,603 | 40,378,608 | |
| 減：營業總成本 | 50,383,129 | 4.09% | 47,194,089 | 43,218,513 | 44,351,267 | 38,790,277 | |
| 其中:營業成本 | 49,008,443 | 4.27% | 45,704,776 | 41,676,318 | 42,837,500 | 37,235,801 | |
| 財務費用 | (21,877) | -67.84% | (126,127) | (28,840) | (18,342) | (6,810) | |
| 資產減值損失 | (5,564) | 421.78% | 389 | (5,140) | (17,588) | (6,479) | |
| 公允價值變動收益 | 66 | -100.36% | 10,817 | -- | -- | -- | |
| 投資收益 | 566,777 | 10.23% | 358,952 | 291,622 | 283,351 | 220,599 | |
| 其中：對聯營企業和合營企業的投資收益 | 546,994 | 6.18% | 456,539 | 380,800 | 380,222 | 327,623 | |
| 營業利潤 | 2,621,664 | -2.08% | 2,944,358 | 2,694,923 | 2,447,274 | 1,913,218 | |
| 利潤總額 | 2,600,143 | -2.01% | 2,930,890 | 2,687,886 | 2,444,806 | 1,917,346 | |
| 減：所得稅費用 | 510,739 | -2.50% | 596,420 | 559,181 | 516,303 | 408,095 | |
| 淨利潤 | 2,089,404 | -1.90% | 2,334,471 | 2,128,705 | 1,928,503 | 1,509,251 | |
| 減：非控股權益 | 92,810 | -28.42% | 188,472 | 164,648 | 174,418 | 126,562 | |
| 股東淨利潤 | 1,996,593 | -0.18% | 2,145,999 | 1,964,058 | 1,754,084 | 1,382,688 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 2.646 | -0.18% | 2.844 | 2.603 | 2.325 | 1.833 | |
| 每股派息 (元) * | 0.800 | 0.00% | 0.854 | 0.782 | 0.700 | 0.550 | |
| 每股淨資產 (元) * | 24.579 | 8.27% | 20.909 | 18.840 | 16.938 | 15.167 | |
| 審計意見 # | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 19/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
